The DISCOVER INOCA Prospective Multi-center Registry

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions
Ischemia and No Obstructive Coronary Artery DiseaseCoronary Microvascular DysfunctionCoronary VasospasmEndothelial DysfunctionMicrovascular AnginaChest Pain With Normal Coronary Angiography
Interventions
DIAGNOSTIC_TEST

Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire

"Patients presenting with symptomatic ischemic heart disease (including chronic stable angina or unstable angina) without evidence of myocardial infarction who require elective or urgent cardiac catheterization, and who meet all eligibility criteria will be enrolled.~Participants will undergo routine coronary angiography as well as comprehensive physiologic assessment with intracoronary acetylcholine provocation for diagnosis of vasospastic angina (VSA), coronary thermodilution to evaluate for coronary microvascular dysfunction (CMD), and intracoronary imaging with optical coherence tomography (OCT) or intravascular ultrasound (IVUS) to evaluate for the presence of atheroma, plaque burden, and myocardial bridging."

Trial Locations (9)

10010

RECRUITING

NYU Langone Health, New York

10032

RECRUITING

Columbia University Irving Medical Center, New York

11215

RECRUITING

New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

30501

RECRUITING

Northeast Georgia Medical Center, Gainesville

45219

RECRUITING

The Christ Hospital, Cincinnati

90095

RECRUITING

UCLA Health, Los Angeles

94305

RECRUITING

Stanford Hospital, Stanford

06520

RECRUITING

Yale New Haven Hospital, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Yale University

OTHER